EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees
| dc.contributor.author | Horwich, Alan | |
| dc.contributor.author | MacLennan, Steven | |
| dc.contributor.author | EAU and ESMO Guidelines Committees | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2020-11-19T00:04:45Z | |
| dc.date.available | 2020-11-19T00:04:45Z | |
| dc.date.issued | 2019-11 | |
| dc.description | ACKNOWLEDGEMENTS The authors would like to thank Peter E Clark from Atrium Health, Levine Cancer Institute, Charlotte, NC, USA, for his contribution to the Delphi survey. Angela Corstorphine of Kstorfin Medical Communications Ltd provided medical writing support with the preparation of this manuscript; this support was funded jointly by EAU and ESMO. FUNDING All costs relating to the consensus conference were covered jointly by the European Association of Urology and the European Society for Medical Oncology. There was no external funding of the event or manuscript production. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 31 | |
| dc.format.extent | 791528 | |
| dc.identifier | 146863386 | |
| dc.identifier | 802d9301-e68f-449a-83a2-81e6699c967d | |
| dc.identifier | 31740927 | |
| dc.identifier | 000507594800008 | |
| dc.identifier | 85077175940 | |
| dc.identifier.citation | Horwich, A, MacLennan, S & EAU and ESMO Guidelines Committees 2019, 'EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees', Annals of Oncology, vol. 30, no. 11, pp. 1697–1727. https://doi.org/10.1093/annonc/mdz296 | en |
| dc.identifier.doi | 10.1093/annonc/mdz296 | |
| dc.identifier.iss | 11 | en |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.other | ORCID: /0000-0002-2691-8421/work/79061765 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15378 | |
| dc.identifier.vol | 30 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Annals of Oncology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | bladder cancer | en |
| dc.subject | consensus | en |
| dc.subject | Delphi | en |
| dc.subject | diagnosis | en |
| dc.subject | treatment | en |
| dc.subject | follow-up | en |
| dc.subject | PROGNOSTIC-FACTORS | en |
| dc.subject | TUMOR RESPONSE | en |
| dc.subject | METASTATIC UROTHELIAL CARCINOMA | en |
| dc.subject | FOLLOW-UP | en |
| dc.subject | SINGLE-ARM | en |
| dc.subject | LONG-TERM-SURVIVAL | en |
| dc.subject | LYMPHOCYTE RATIO | en |
| dc.subject | CISPLATIN-INELIGIBLE PATIENTS | en |
| dc.subject | TRANSITIONAL-CELL CARCINOMA | en |
| dc.subject | RADICAL CYSTECTOMY | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
| dc.subject.lcc | R1 | en |
| dc.subject.lcc | RC0254 | en |
| dc.title | EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- EAU_ESMO_Bladder_Cancer_Consensus_Ann_Oncol_AAM_and_SI.pdf
- Size:
- 772.98 KB
- Format:
- Adobe Portable Document Format
